Li-Kuo Su, Editor-in-Chief of Cancer Cell will join us at the Hotel Alimara, Monday 14 January 2013, 09:00 – 10:15, to deliver the 5th in VHIO´s prestigious series of VHIO Meet the Editors talks:
Cancer Cell and the Cancer Research Community
Related Posts
First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
• The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving…
24 Feb 2013
World Breast Cancer Day 2013: marking seven years´ Breast Cancer Research Foundation support for VHIO
Joaquín Arribas, Director of Preclinical Research at VHIO, this week joined 165 of the world´s leading breast cancer researchers in…
16 Oct 2013
The Spanish Association Against Cancer (AECC): spurring VHIO research and improved therapeutic strategies against cancer
Barcelona, September 15, 2015– We can only hope to collectively accelerate the pace in advancing more precisely targeted therapies against…
16 Sep 2015
World authorities on prostate cancer to discuss and debate latest advances
- Much of the on-going research in prostate cancer focuses on patients suffering disease relapse through resistance to conventional hormone therapy. Castration-resistant prostate cancer (CRPC) accounts for between 20 and 30% of all prostate cancers.
- With significant advances in the treatment of CRPC over recent years, the life expectancy of patients has increased from 12 months in 2004, to 3 – 4 years today.
- A half-day workshop, organised by the Vall d’ Hebron Institute of Oncology (VHIO), attended by renowned experts within the field, will update on the latest advances in prostate cancer, which has the highest incidence of all cancers in men.
23 May 2013
NEJM:Two-drug combination, nab-paclitaxel and gemcitabine, improves survival in pancreatic cancer
• Investigators at the Vall d´Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO), have participated in an…
17 Oct 2013
Global leader in oncology José Baselga awarded the Catalonia International Prize
The XXVIII Catalonia International Prize recognizes trio of internationally acclaimed experts in oncology: José Baselga, Manel Esteller, and Joan Massagué…
24 Jul 2016
VHIO joins 13 partner-strong consortium aimed at combating colorectal cancer
Announced today by lead partner Queen´s University Belfast, Northern Ireland, UK, a new European Consortium MErCuRIC comprised of 13 globally…
11 Dec 2013
Marking Breast Cancer Awareness Month 2014: VHIO and the Vall d´Hebron University Hospital launch series of workshops for breast cancer patients
Barcelona, 16 October 2014. The Vall d´Hebron Institute of Oncology (VHIO) and the Vall d´Hebron University Hospital (HUVH) have joined…
16 Oct 2014
Conflicting interpretations of genetic variants and cancer risk: time to speak the same language
Important advances in next-generation whole-genome sequencing for precision oncology have led to the development of multiplex panel testing for the…
05 Oct 2016
Novel biomarker identified for monitoring response to colorectal cancer therapy in plasma
Recent VHIO study reveals that tumor cell sensitivity and resistance to therapy with cetuximab in colorectal cancer can be detected…
30 Oct 2014
In celebration of improved outcomes for cancer patients driven by science: 24 September marks World Cancer Research Day
Established in 2016 by the Spanish Association against Cancer (AECC) and officially promoted in collaboration with leading organizations and societies*,…
19 Sep 2017
ICREA celebrates 15 years fortifying Catalonia-based research of excellence
ICREA – the Catalan Institution for Research and Advanced Studies, founded back in 2001 with the support of the Catalan…
29 Jun 2016
VI Annual FERO Grant to support 3D study of tumor DNA
This year´s annual Fero Foundation (Fundación de Investigación Oncológica) Grant for Translational Research, amounting to 70,000 EUR was presented Monday 12 May, to Sandra Peiró for a two year research project aimed at determining the three-dimensional structure of the tumor cell genome with emphasis on tumor progression and metastatis.
15 May 2014
International study published in The Lancet shows efficacy of new gastric cancer drug
The phase III study, published in the prestigious scientific journal, The Lancet, in which researchers at the Vall d´Hebron University…
03 Oct 2013
Abstract submission for the VHIO-Fritz Bender Foundation joint International Symposium on Progress Towards Individualized Cancer Treatments, 07 – 09 November 2013, Barcelona.
Abstract submission and Registration for the VHIO-Fritz Bender Foundation joint International Symposium on Progress Towards Individualized Cancer Treatments, 07 –…
07 Oct 2013
